Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes
1 other identifier
interventional
200
1 country
1
Brief Summary
Preterm premature rupture of membrane is associated with increased oxidative stress and inflammatory process, enhancing the activity or the availability of antioxidants may modulate the inflammatory response associated with PPROM, thereby reducing oxidative stress and the risk to the fetus. In this study the investigators sought to determine the effects of Pomegranate 1. On the patients (maternal and fetal) oxidative stress and inflammation associated with PPROM. 2. On the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 16, 2014
CompletedFirst Posted
Study publicly available on registry
February 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedFebruary 24, 2014
January 1, 2014
1 year
February 16, 2014
February 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Maternal and fetal oxidative stress
Maternal and fetal oxidative stress will be determined by blood tests.
10 weeks
Maternal and fetal oxidative stress
Maternal blood and umbilical cord blodd will be drawn following delivery and oxidative blood markers inflammatory mediators will be assessed
10 weeks
Secondary Outcomes (2)
Time interval from PPROM to delivery
10 weeks
time interval from PPROM to delivery
10 weeks
Study Arms (1)
Pomegranate
EXPERIMENTALThe women in this group will drink pomegranate juice
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant patients
- admitted with PPROM
- between 24-32 weeks of gestation
You may not qualify if:
- Women with contractions
- abruption
- monochorionic multiple pregnancy
- abnormal (non-reassuring) cardiotocogram
- meconium-stained amniotic fluid
- signs of intrauterine infection
- major fetal anomalies
- hemolysis
- elevated liver enzymes
- low platelets (HELLP syndrome); or severe preeclampsia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hillel Yaffe Medical Center
Hadera, 38100, Israel
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
ron beloosesky
Hillel Yaffe Medical center technion
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2014
First Posted
February 24, 2014
Study Start
February 1, 2014
Primary Completion
February 1, 2015
Study Completion
April 1, 2015
Last Updated
February 24, 2014
Record last verified: 2014-01